Menu

AbbVie Inc. ABBV

Full chart Compare
Set alert

Price alert · ABBV

All alert types
293.30 USD +1.99 (+0.68%)

At closeNov 9, 2026, 6:08 PM EST

293.80 +0.50 +0.17%

After hours · Nov 9, 6:08 PM ET

289.62 Day range 294.57
190.75 52-week range 302.93
YTD
+28.36%
1 year
+33.83%

Revenue & Expenses

Revenue → Gross Profit: $42.96BGross Profit → Net Income: $4.23BGross Profit → Selling, General & Admin: $14.01BGross Profit → Research & Development: $9.10BRevenue → Cost of Revenue: $18.20BGross Profit → Other Operating Expenses: $4.78BGross Profit → Interest Expense: $2.63BGross Profit → Other Expenses: $5.86BGross Profit → Income Tax: $2.36BGross Profit$42.96BCost of Revenue$18.20BNet Income$4.23BSelling, General & Admin$14.01BResearch & Development$9.10BOther Operating Expenses$4.78BInterest Expense$2.63BOther Expenses$5.86BIncome Tax$2.36BRevenue$61.16B

Latest period ending Dec 31, 2025 · select a line to chart its full history

ABBV annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
61.16B56.33B54.32B58.05B56.20B
42.96B39.43B33.90B40.64B38.75B
15.07B9.14B12.76B18.12B17.92B
4.23B4.28B4.86B11.84B11.54B
2.362.392.726.636.45
ABBV annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
5.23B5.52B12.81B9.20B9.75B
133.96B135.16B134.71B138.81B146.53B
137.23B131.80B124.31B121.52B131.09B
67.50B67.14B59.38B63.27B76.68B
-3.31B3.33B10.36B17.25B15.41B
ABBV annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
19.03B18.81B22.84B24.94B22.78B
-6.64B-20.82B-2.01B-623.00M-2.34B
-12.72B-5.21B-17.22B-24.80B-19.04B
-1.21B-974.00M-777.00M-695.00M-787.00M
-295.00M-7.29B3.61B-545.00M1.30B